Rennova Health Inc (RNVA)

[powerbattles]

Question! "I'm an owner of RNVA shares but I have a valid question that may or may not have been asked yet. Why did RNVA go from $54 a year ago to under a half penny this year and why do we think they'll do well going forward?

PennySheik, That is a great question that deserves an answer. I am not the expert nor special financial analysts. My post is to contribute the best of my knowledge sharing with you and to whom it may concern that truly care about RNVA fundamentals.

I don't have the ability to write an effective summary. All I can do is summarize the most important key factors to answer your question.

$RNVA SUBSIDIARY MEDYTOX. Fast-Growing Chain of Labs, Medytox Diagnostics



Medytox (OTCBB: MMMS) This is the holding company.
Medytox Diagnostics, Inc., which owns and operates half a dozen clinical laboratories throughout the U.S.

On Apr 16, 2015 CollabRx (Nasdaq:CLRX) and Medytox have reached a definitive merger agreement.

"CollabRx posted revenues of $415,000 and a net loss of $4.3 million in 2014. Medytox recorded $57.9 million in revenues and a net income attributable to the firm of $7.8 million last year.
https://www.genomeweb.com/business-news/collabrx-medytox-reach-merger-agreement

On October 28, 2015 Medytox Solutions, Inc. Stockholders Approve Merger With CollabRx, Inc.
"Assuming completion of the transaction, the combined company will be known as Rennova Health, Inc. and trade under the symbol "RNVA" beginning at market open on November 3, 2015.

On December 19, 2016 Rennova Health, Inc. Prices $12,350,000 Public Offering Move to NASDAQ under the symbol RNVA.

Here's where the trouble started.

"an underwritten public offering of 12,350 shares of its Series H Convertible Preferred Stock at a per share price to the public of $1,000. The Series H Preferred Stock has a stated value of $1,000 per share with each share convertible into 11,111 shares of common stock, at a conversion price of $0.09 per share.

RNVA share structure that extremely low. With a conversion price of $0.09 per share, that is what caused the trouble to take place. The noteholders had no mercy. Massive conversion disasters occurred. RNVA failed to meet the NASDAQ requirements.

Because they needed to stay on NASDAQ, they had no other choice to move forward with the R/S. During the year 2017, they did two r/s.

Keep in mind most of the toxic occurs is because the work they did for (CIGNA) "THEY WERE UNABLE TO COLLECT THE MONEY".

At that time they desperately need the money for working capital. Inadequate access to working capital plus other financing option disadvantages deficiency leads to massive disaster toxic conversion caused the downgrade to the OCT market.

Capital expenditure from operational spent to perform the work for
(CIGNA) estimated over 10 million dollars unpaid. This case was battle at the court. RNVA won an appeal in the Eleventh Circuit Court of Appeals in a lawsuit filed by Rennova against CIGNA for failure to pay claims for laboratory services.

The problem with the old company financially was too deep in debt. Mr. Lagan did a damn good job. He managed the company keeping it alive. On top of that, he paid off most debts, stop the toxic notes convert by restructured the Old debt due in Sept 2019. If that is not enough he has acquired new hospital and more set to close June 1, 2018. Follow the close of the hospital is the SPIN-OFF. Might be 2 spin-off FREE SHARES for the loyal shareholders.

RNVA right now is on the edge of turning around. Furthermore, they're getting out of the deep chit by paid off most of the debts, on the target moving forward break even with net profit.

People lack understanding, clueless on how to read the Audited financial. For god sake why keep spilling garbages screaming they lose $52 million dollars this year?

First, if you looking at the Logic and commonsense... heck, they don't have $52 million so how in the world they lose something that they don't have? ROTFLMAO.

PEEP NEED TO WAKE UP LET'S GET IT CORRECT.

Total liabilities is a useful metric for analyzing a company's operations. Higher dollar amounts of total liabilities is not a financial indicator of poor economic quality of an entity.

All assets of an entity are either owned by the entity and classified as equity or are subject to future obligations and are classified as a liability.

I can go on...but ya should get the picture... this is enough from my end.

Good times ahead. The toxic notes disasters are no longer in effect. We are sitting at the bottom of the barrel. The downside is Min but the upside virtually unlimited.

One more thing. The a/s increased is for the insurance.

ANY NEW NOTE ISSUE MUST FILE WITH THE SEC. RNVA IS THE REAL DEAL AUDIT FINANCIAL. LET'S ME MAKE IS CLEAR. THIS IS NOT THE PINKY POS WHICH COMPANY CAN DUMP SHARE ON THE BACK DOOR.
[IMHO:))